EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.
EyeD Pharma has raised $51.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2021.
EyeD Pharma's investors include Fund+, Meusinvest (Noshaq), S.R.I.W., SFPI-FPIM, QBIC II.
EyeD Pharma is headquartered in Liège, Belgium.
EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.
EyeD Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EyeD Pharma — Funding & Investors." VCBacked, December 24, 2021, https://www.vcbacked.co/company/eyed-pharma. Accessed August 18, 2026.
VCBacked. (2021). EyeD Pharma — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/eyed-pharma
{{cite web |title=EyeD Pharma — Funding & Investors |url=https://www.vcbacked.co/company/eyed-pharma |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated